Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) EPS (Weighted Average and Diluted) (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.0 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 47.06% to -$0.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$0.0, a 97.14% decrease, with the full-year FY2025 number at -$0.0, up 16.67% from a year prior.
  • EPS (Weighted Average and Diluted) reached -$0.0 in Q1 2026 per CBIH's latest filing, up from -$0.0 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.0 in Q3 2024, with the low at -$0.0 in Q2 2025.
  • A 5-year average of -$0.0 and a median of -$0.0 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Year-over-year, EPS (Weighted Average and Diluted) skyrocketed 65.0% in 2024 and then tumbled 368.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.0 in 2022, then skyrocketed by 60.05% to -$0.0 in 2023, then rose by 20.0% to -$0.0 in 2024, then dropped by 25.0% to -$0.0 in 2025, then grew by 10.0% to -$0.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's EPS (Weighted Average and Diluted) are -$0.0 (Q1 2026), -$0.0 (Q4 2025), and -$0.0 (Q3 2025).